|
NASH | Abstract Library |
 |
|
The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
|
|
|
|
|
|
|
|
|
|
|
|
7. | Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat |
|
Clin Gastroenterol Hepatol. 2023 Jan;21(1):143-152.e3.doi: 10.1016/j.cgh.2021.12.044. Epub 2022 Jan 6.
Eric J Lawitz 1, Bal Raj Bhandari 2, Peter J Ruane 3, Anita Kohli 4, Eliza Harting 5, Dora Ding 5, Jen-Chieh Chuang 5, Ryan S Huss 5, Chuhan Chung 5, Robert P Myers 5, Rohit Loomba 6
|
|
|
|
|
|
|
|
|
11. | A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis |
|
JHEP Rep. 2022 Aug 23;5(1):100563. doi: 10.1016/j.jhepr.2022.100563. eCollection 2023 Jan.
Stephen A Harrison 1, Peter J Ruane 2, Bradley Freilich 3, Guy Neff 4, Rashmee Patil 5, Cynthia Behling 6, Chen Hu 7, Reshma Shringarpure 8, Brittany de Temple 8, Erica Fong 8, Erik J Tillman 8, Timothy Rolph 8, Andrew Cheng 8, Kitty Yale 8
|
|
|
|
|
13. | A multistakeholder approach to innovations in NAFLD care |
|
Commun Med (Lond)\. 2023 Jan 3;3(1):1. doi: 10.1038/s43856-022-00228-y.
Jörn M Schattenberg 1, Alina M Allen 2, Helen Jarvis 3, Shira Zelber-Sagi 4 5, Ken Cusi 6, John F Dillon 7, Cyrielle Caussy 8 9, Sven M Francque 10 11, Zobair Younossi 12, Naim Alkhouri 13, Jeffrey V Lazarus 14 15 16
|
|
|
14. | Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis |
|
Lancet Gastroenterol Hepatol. 2023 Jan;8(1):20-30.doi: 10.1016/S2468-1253(22)00317-X. Epub 2022 Nov 16.
Jingxuan Quek 1, Kai En Chan 1, Zhen Yu Wong 2, Caitlyn Tan 1, Bryan Tan 1, Wen Hui Lim 1, Darren Jun Hao Tan 1, Ansel Shao Pin Tang 1, Phoebe Tay 1, Jieling Xiao 1, Jie Ning Yong 1, Rebecca Wenling Zeng 1, Nicholas W S Chew 3, Benjamin Nah 4, Anand Kulkarni 5, Mohammad Shadab Siddiqui 6, Yock Young Dan 7, Vincent Wai-Sun Wong 8, Arun J Sanyal 6, Mazen Noureddin 9, Mark Muthiah 10, Cheng Han Ng 1
|
|
|
|
|
|
|
17. | Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials |
|
Clin Gastroenterol Hepatol. 2023 Jan;21(1):90-102.e6.doi: 10.1016/j.cgh.2022.01.015. Epub 2022 Jan 22.
Vincent Wai-Sun Wong 1, Won Young Tak 2, George Boon Bee Goh 3, Pin-Nan Cheng 4, Eric J Lawitz 5, Zobair M Younossi 6, Raj Vuppalanchi 7, Ziad Younes 8, Naim Alkhouri 9, Lulu Wang 10, Jialuo Liu 10, Kathryn Kersey 10, Robert P Myers 10, Stephen A Harrison 11, Zachary Goodman 6, Michael Trauner 12, Manuel Romero-Gomez 13, Quentin M Anstee 14, Mindie H Nguyen 15, Takeshi Okanoue 16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29. | High-Intensity Interval Training is Safe, Feasible and Efficacious in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial |
|
Dig Dis Sci. 2022 Dec 20;1-17. doi: 10.1007/s10620-022-07779-z. Online ahead of print.
Shelley E Keating 1, Ilaria Croci 2 3 4, Matthew P Wallen 5 6, Emily R Cox 7, Moe Thuzar 8 9, Uyen Pham 10 11 12, Gregore I Mielke 13, Jeff S Coombes 2, Graeme A Macdonald 12 14, Ingrid J Hickman 12 15
|
|
|
30. | A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis |
|
Aliment Pharmacol Ther. 2023 Feb;57(3):304-312. doi: 10.1111/apt.17346. Epub 2022 Dec 13.
Zobair Younossi 1 2 3, Naim Alkhouri 4, Ken Cusi 5, Scott Isaacs 6, Fasiha Kanwal 7, Mazen Noureddin 8, Rohit Loomba 9, Natarajan Ravendhran 10, Brian Lam 2 3, Khalil Nader 11 12, Andrei Racila 2 3 12, Fatema Nader 12, Linda Henry 2 3 12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38. | Upper gut heat shock proteins HSP70 and GRP78 promote insulin resistance, hyperglycemia, and non-alcoholic steatohepatitis |
|
Nat Commun. 2022 Dec 13;13(1):7715. doi: 10.1038/s41467-022-35310-5.
Giulia Angelini 1 2, Lidia Castagneto-Gissey 3, Serenella Salinari 4, Alessandro Bertuzzi 5, Danila Anello 1, Meenakshi Pradhan 6, Marlen Zschätzsch 7 8, Paul Ritter 9, Carel W Le Roux 10, Francesco Rubino 11, Nicola Basso 3, Giovanni Casella 3, Stefan R Bornstein 12 13, Valentina Tremaroli 6, Geltrude Mingrone 14 15 16
|
|
|
|
|
|
|
|
|
|
|
43. | Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non-alcoholic Steatohepatitis |
|
Clin Pharmacol Ther. 2022 Dec;112(6):1271-1279. doi: 10.1002/cpt.2745.Epub 2022 Sep 27.
Atoosa Rabiee # 1, Martha D Gay # 2, Narayan Shivapurkar 2, Hong Cao 2, Sandeep Nadella 3, Coleman I Smith 3, James H Lewis 3, Sunil Bansal 2, Amrita Cheema 2, John Kwagyan 4, Jill P Smith 1 2
|
|
|
|
|
45. | Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment |
|
J Clin Transl Hepatol. 2023 Apr 28;11(2):502-515. doi: 10.14218/JCTH.2022.00204.Epub 2022 Dec 23.
Ankoor H Patel 1 2, Dhiraj Peddu 1 2, Sahil Amin 1 2, Mohamed I Elsaid 3 4, Carlos D Minacapelli 1 2, Toni-Marie Chandler 1 2, Carolyn Catalano 1 2, Vinod K Rustgi 1 2
|
|
|
46. | Non-Alcoholic Fatty Liver Disease, Heart Failure, and Long-Term Mortality: Insights From the National Health and Nutrition Examination Survey |
|
Curr Probl Cardiol. 2022 Dec;47(12):101333. doi: 10.1016/j.cpcardiol.2022.101333.Epub 2022 Jul 25.
Abdul Mannan Khan Minhas 1, Vardhmaan Jain 2, Muhammad Haisum Maqsood 3, Ambarish Pandey 4, Sadiya S Khan 5, Marat Fudim 6, Gregg C Fonarow 7, Javed Butler 8, Muhammad Shahzeb Khan 9
|
|
|
47. | Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled Trial |
|
Ann Intern Med. 2023 Jan;176(1):10-21. doi: 10.7326/M22-1787.Epub 2022 Dec 13.
Camilla Dalby Hansen 1, Eva-Marie Gram-Kampmann 2, Johanne Kragh Hansen 3, Mie Balle Hugger 1, Bjørn Stæhr Madsen 3, Jane Møller Jensen 3, Sara Olesen 3, Nikolaj Torp 1, Ditlev Nytoft Rasmussen 3, Maria Kjærgaard 1, Stine Johansen 1, Katrine Prier Lindvig 4, Peter Andersen 3, Katrine Holtz Thorhauge 1, Jan Christian Brønd 5, Pernille Hermann 6, Henning Beck-Nielsen 2, Sönke Detlefsen 7, Torben Hansen 8, Kurt Højlund 2, Maja Sofie Thiele 1, Mads Israelsen 3, Aleksander Krag 9
|
|
|
48. | SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT Forum |
|
J Gastroenterol. 2022 Dec 5;1-19. doi: 10.1007/s00535-022-01932-1.Online ahead of print.
Yoshihiro Kamada 1, Takahiro Nakamura 2, Satoko Isobe 3, Kumiko Hosono 4, Yukiko Suama 5, Yukie Ohtakaki 6, Arihito Nauchi 7, Naoto Yasuda 8, Soh Mitsuta 3, Kouichi Miura 9, Takuma Yamamoto 10, Tatsunori Hosono 11, Akihiro Yoshida 12, Ippei Kawanishi 13, Hideaki Fukushima 14, Masao Kinoshita 15, Atsushi Umeda 16, Yuichi Kinoshita 17, Kana Fukami 18, Toshio Miyawaki 5, Hideki Fujii 19, Yuichi Yoshida 20, Miwa Kawanaka 21, Hideyuki Hyogo 22 23, Asahiro Morishita 24, Hideki Hayashi 25, Hiroshi Tobita 26, Kengo Tomita 27, Tadashi Ikegami 28, Hirokazu Takahashi 29, Masato Yoneda 30, Dae Won Jun 31, Yoshio Sumida 32, Takeshi Okanoue 33, Atsushi Nakajima 30; JANIT Forum
|
|
|
|
|
|
|
51. | Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study |
|
Lancet Gastroenterol Hepatol. 2023 Feb;8(2):120-132.doi: 10.1016/S2468-1253(22)00347-8. Epub 2022 Dec 12.
Rohit Loomba 1, Eric J Lawitz 2, Juan Pablo Frias 3, Grisell Ortiz-Lasanta 4, Lars Johansson 5, Bridgette Boggess Franey 6, Linda Morrow 7, Moti Rosenstock 8, Cynthia L Hartsfield 9, Chao-Yin Chen 9, Leo Tseng 9, R Will Charlton 9, Hank Mansbach 9, Maya Margalit 10
|
|
|
52. | Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial |
|
Cell Metab. 2023 Jan 3;35(1):56-70.e3.doi: 10.1016/j.cmet.2022.12.001. Epub 2022 Dec 21.
Mark Ezpeleta 1, Kelsey Gabel 1, Sofia Cienfuegos 1, Faiza Kalam 1, Shuhao Lin 1, Vasiliki Pavlou 1, Zhenyuan Song 1, Jacob M Haus 2, Sean Koppe 3, Shaina J Alexandria 4, Lisa Tussing-Humphreys 1, Krista A Varady 5
|
|
|
|
|
54. | A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markers |
|
Panminerva Med. 2022 Dec;64(4):485-496.doi: 10.23736/S0031-0808.22.04590-6. Epub 2022 Apr 19.
Nuria Perez-Diaz-Del-Campo 1, Jose I Riezu-Boj 1 2, Bertha A Marin-Alejandre 1, J Ignacio Monreal 2 3, Mariana Elorz 2 4, José I Herrero 2 5 6, Alberto Benito-Boillos 2 4, Fermín I Milagro 1 2 7, Elisabetta Bugianesi 8, Josep A Tur 7 9, J Alfredo Martinez 10 2 7, Itziar Abete 1 2 7, M Angeles Zulet 1 2 7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70. | NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity? |
|
Semin Liver Dis. 2022 Nov;42(4):465-474. doi: 10.1055/s-0042-1757712.Epub 2022 Oct 14.
Bing Chen 1, W H Wilson Tang 2, Mario Rodriguez 3, Kathleen E Corey 4, Arun J Sanyal 5, Patrick S Kamath 6, Biykem Bozkurt 7, Hafeez Ul Hassan Virk 8, Gregg S Pressman 9, Jeffrey V Lazarus 10 11, Hashem B El-Serag 12 13, Chayakrit Krittanawong 14
|
|
|
|
|
|
|
73. | Pulse-Echo Quantitative US Biomarkers for Liver Steatosis: Toward Technical Standardization |
|
Radiology. 2022 Nov;305(2):265-276. doi: 10.1148/radiol.212808.Epub 2022 Sep 13.
David T Fetzer # 1, Ivan M Rosado-Mendez # 1, Michael Wang 1, Michelle L Robbin 1, Arinc Ozturk 1, Keith A Wear 1, Juvenal Ormachea 1, Timothy A Stiles 1, J Brian Fowlkes 1, Timothy J Hall 1, Anthony E Samir 1
|
|
|
|
|
75. | Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis |
|
Clin Gastroenterol Hepatol. 2022 Nov;20(11):2451-2461.e3.doi: 10.1016/j.cgh.2021.09.041. Epub 2021 Oct 7.
Anneli Andersson 1, Matt Kelly 1, Kento Imajo 2, Atsushi Nakajima 2, Jonathan A Fallowfield 3, Gideon Hirschfield 4, Michael Pavlides 5, Arun J Sanyal 6, Mazen Noureddin 7, Rajarshi Banerjee 1, Andrea Dennis 8, Stephen Harrison 9
|
|
|
|
|
|
|
|
|
79. | Multiomics study of nonalcoholic fatty liver disease |
|
Nat Genet. 2022 Nov;54(11):1652-1663. doi: 10.1038/s41588-022-01199-5. Epub 2022 Oct 24.
Gardar Sveinbjornsson # 1, Magnus O Ulfarsson # 2 3, Rosa B Thorolfsdottir 2, Benedikt A Jonsson 2, Eythor Einarsson 2, Gylfi Gunnlaugsson 2, Solvi Rognvaldsson 2, David O Arnar 2 4 5, Magnus Baldvinsson 6, Ragnar G Bjarnason 4 7, DBDS Genomic consortium; Thjodbjorg Eiriksdottir 2, Christian Erikstrup 8, Egil Ferkingstad 2, Gisli H Halldorsson 2, Hannes Helgason 2, Anna Helgadottir 2, Lotte Hindhede 8, Grimur Hjorleifsson 2, David Jones 9, Kirk U Knowlton 10, Sigrun H Lund 2, Pall Melsted 2 11, Kristjan Norland 2, Isleifur Olafsson 12, Sigurdur Olafsson 5, Gudjon R Oskarsson 2, Sisse Rye Ostrowski 13 14, Ole Birger Pedersen 14 15, Auðunn S Snaebjarnarson 2, Emil Sigurdsson 16 17, Valgerdur Steinthorsdottir 2, Michael Schwinn 13, Gudmundur Thorgeirsson 2 5, Gudmar Thorleifsson 2, Ingileif Jonsdottir 2 4, Henning Bundgaard 14 18, Lincoln Nadauld 9, Einar S Bjornsson 4 5, Ingrid C Rulifson 19, Thorunn Rafnar 2, Gudmundur L Norddahl 2, Unnur Thorsteinsdottir 2 4, Patrick Sulem 2, Daniel F Gudbjartsson 2 3 20, Hilma Holm 2, Kari Stefansson 21 22
|
|
|
80. | Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease |
|
Clin Gastroenterol Hepatol. 2022 Oct;20(10):2276-2286.e6.doi: 10.1016/j.cgh.2021.10.023. Epub 2021 Oct 21.
Octavi Bassegoda 1, Pol Olivas 2, Laura Turco 3, Mattias Mandorfer 4, Miquel Serra-Burriel 5, Luis Tellez 6, Wilhelmus Kwanten 7, Alexia Laroyenne 8, Oana Farcau 9, Edilmar Alvarado 10, Lucile Moga 11, Elise Vuille-Lessard 12, Jose Ignacio Fortea 13, Luis Ibañez 14, Giulia Tosetti 15, Thomas Vanwolleghem 7, Hélène Larrue 8, Diego Burgos-Santamaría 16, Horia Stefanescu 9, Rafael Paternostro 4, Annalisa Cippitelli 3, Sabela Lens 1, Salvador Augustin 17, Elba Llop 18, Wim Laleman 19, Jonel Trebicka 20, Johannes Chang 21, Helena Masnou 22, Alexander Zipprich 23, Francesca Miceli 3, Georg Semmler 4, Xavier Forns 1, Massimo Primignani 15, Rafael Bañares 14, Angela Puente 13, Annalisa Berzigotti 12, Pierre Emmanuel Rautou 11, Candid Villanueva 10, Pere Ginès 1, J C Garcia-Pagan 2, Bogdan Procopet 9, Cristophe Bureau 8, Agustin Albillos 6, Sven Francque 7, Thomas Reiberger 4, Filippo Schepis 3, Isabel Graupera 24, Virginia Hernandez-Gea 25
|
|
|
|
|
82. | Rencofilstat, a cyclophilin inhibitor: A phase 2a, multicenter, single-blind, placebo-controlled study in F2/F3 NASH |
|
Hepatol Commun. 2022 Oct 22. doi: 10.1002/hep4.2100. Online ahead of print.
Stephen A Harrison 1, Patrick R Mayo 2, Todd M Hobbs 3, Carlos Canizares 3, Erin P Foster 2, Caroline Zhao 2, Daren R Ure 2, Daniel J Trepanier 2, Jill A Greytok 3, Robert T Foster 2
|
|
|
83. | Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational Cohort |
|
Clin Gastroenterol Hepatol. 2022 Oct;20(10):2393-2395.e4.doi: 10.1016/j.cgh.2021.01.023. Epub 2021 Jan 21.
Miguel H Malespin 1, Alfred Sidney Barritt 4th 2, Stephanie E Watkins 3, Cheryl Schoen 3, Monica A Tincopa 4, Karen D Corbin 5, Andrea R Mospan 3, Breda Munoz 3, Huy N Trinh 6, L Michael Weiss 7, K Rajender Reddy 8, Rohit Loomba 9, Nyingi Kemmer 1, Anna S Lok 10
|
|
|
|
|
85. | Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality |
|
Front Med (Lausanne). 2022 Oct 6;9:985803. doi: 10.3389/fmed.2022.985803.eCollection 2022.
Cheng Han Ng 1, Jieling Xiao 1, Nicholas W S Chew 1 2, Yip Han Chin 1, Kai En Chan 1, Jingxuan Quek 1, Wen Hui Lim 1, Darren Jun Hao Tan 1, Ryan Wai Keong Loke 1, Caitlyn Tan 1, Ansel Shao Pin Tang 1, Xin Lei Goh 1, Benjamin Nah 3, Nicholas Syn 1, Dan Yock Young 1 3 4, Nobuharu Tamaki 5, Daniel Q Huang 1 3 4, Mohammad Shadab Siddiqui 6, Mazen Noureddin 7, Arun Sanyal 6, Mark Muthiah 1 3 4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
92. | A Meta-analysis on Associated Risk of Mortality in Nonalcoholic Fatty Liver Disease |
|
Endocr Pract. 2022 Oct 20;S1530-891X(22)00648-6. doi: 10.1016/j.eprac.2022.10.007.Online ahead of print.
Clarissa Elysia Fu 1, Cheng Han Ng 2, Jie Ning Yong 1, Kai En Chan 1, Jieling Xiao 1, Benjamin Nah 3, Shirley Huey Shin Bong 4, Khin Maung Win 5, Aung Hlaing Bwa 5, Wen Hui Lim 1, Darren Jun Hao Tan 1, Rebecca Wenling Zeng 1, Nicholas Chew 6, Margaret L P Teng 3, Mohammad Shadab Siddiqui 7, Jude A Oben 8, Arun J Sanyal 7, Vincent Wai-Sun Wong 9, Mazen Noureddin 10, Mark Muthiah 11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
106. | Incidence and Impact of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients with Adenocarcinoma of the Esophagus Treated with Curative Intent |
|
World J Surg. 2022 Oct 20. doi: 10.1007/s00268-022-06781-w. Online ahead of print.
John V Reynolds 1, Noel E Donlon 2, Jessie A Elliott 2, Brendan Moran 2, Hugo Temperley 2, Tim S Nugent 2, Maria Davern 2, Sinead King 2, Melissa Conroy 2, Joanne Lysaght 2, Narayanasamy Ravi 2, Carmel Ryan 3, Stephen Finn 3, Suzanne Norris 4, Clare L Donohoe 2
|
|
|
107. | Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles |
|
Hepatology. 2022 Oct;76(4):1121-1134. doi: 10.1002/hep.32427. Epub 2022 Mar 17.
Ibon Martínez-Arranz 1, Chiara Bruzzone 2, Mazen Noureddin 3, Ruben Gil-Redondo 2, Itziar Mincholé 1, Maider Bizkarguenaga 2, Enara Arretxe 1, Marta Iruarrizaga-Lejarreta 1, David Fernández-Ramos 2, Fernando Lopitz-Otsoa 2, Rebeca Mayo 1, Nieves Embade 2, Elizabeth Newberry 4, Bettina Mittendorf 5, Laura Izquierdo-Sánchez 6, Vaclav Smid 7, Jorge Arnold 8, Paula Iruzubieta 9, Ylenia Pérez Castaño 10, Marcin Krawczyk 11 12, Urko M Marigorta 2, Martine C Morrison 13, Robert Kleemann 13, Antonio Martín-Duce 14, Liat Hayardeny 15, Libor Vitek 7, Radan Bruha 7, Rocío Aller de la Fuente 16, Javier Crespo 9, Manuel Romero-Gomez 17, Jesus M Banales 6 18, Marco Arrese 8 19, Kenneth Cusi 20, Elisabetta Bugianesi 21, Samuel Klein 5, Shelly C Lu 3, Quentin M Anstee 22 23, Oscar Millet 2, Nicholas O Davidson 4, Cristina Alonso 1, José M Mato 2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
121. | Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis |
|
Nutr Metab Cardiovasc Dis. 2022 Oct;32(10):2279-2288.doi: 10.1016/j.numecd.2022.07.001. Epub 2022 Jul 16.
Grazia Pennisi 1, Ciro Celsa 1, Marco Enea 2, Marco Vaccaro 2, Vito Di Marco 1, Carlo Ciccioli 1, Giuseppe Infantino 1, Claudia La Mantia 1, Stefanie Parisi 1, Federica Vernuccio 3, Antonio Craxì 1, Calogero Cammà 1, Salvatore Petta 4
|
|
|
|
|
123. | The Impact of Bariatric-Surgery-Induced Weight Loss on Patients Undergoing Liver Transplant: A Focus on Metabolism, Pathophysiological Changes, and Outcome in Obese Patients Suffering NAFLD-Related Cirrhosis |
|
J Clin Med. 2022 Sep 8;11(18):5293. doi: 10.3390/jcm11185293.
Gerardo Sarno 1, Luigi Schiavo 2 3, Pietro Calabrese 2 3, Ludwig Álvarez Córdova 4, Evelyn Frias-Toral 5 6, Gabriela Cucalón 7, Eloisa Garcia-Velasquez 8, Vanessa Fuchs-Tarlovsky 9, Vincenzo Pilone 2 3
|
|
|
|
|
125. | Combination Treatment with Hydroxytyrosol and Vitamin E Improves NAFLD-Related Fibrosis |
|
Nutrients. 2022 Sep 14;14(18):3791.
Nadia Panera 1, Maria Rita Braghini 1, Annalisa Crudele 1, Antonella Smeriglio 2, Marzia Bianchi 1, Angelo Giuseppe Condorelli 3, Rebecca Nobili 3, Libenzio Adrian Conti 4, Cristiano De Stefanis 4, Gessica Lioci 5, Fabio Gurrado 5, Donatella Comparcola 6, Antonella Mosca 6, Maria Rita Sartorelli 6, Vittorio Scoppola 1, Gianluca Svegliati-Baroni 7 8, Domenico Trombetta 2, Anna Alisi 1
|
|
|
|
|
127. | Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes |
|
Diabetes Metab. 2022 Sep;48(5):101363. doi: 10.1016/j.diabet.2022.101363. Epub 2022 Jun 24.
Erminia Lembo 1, Maria Francesca Russo 1, Ornella Verrastro 1, Danila Anello 1, Giulia Angelini 1, Amerigo Iaconelli 1, Caterina Guidone 1, Gianluigi Stefanizzi 1, Luigi Ciccoritti 1, Francesco Greco 1, Luca Sessa 1, Laura Riccardi 1, Maurizio Pompili 1, Marco Raffaelli 1, Fabio Maria Vecchio 1, Stefan R Bornstein 2, Geltrude Mingrone 3, Amalia Gastaldelli 4, Esmeralda Capristo 1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
140. | Disease State Transition Probabilities Across the Spectrum of NAFLD: A Systematic Review and Meta-Analysis of Paired Biopsy or Imaging Studies |
|
Clin Gastroenterol Hepatol. 2022 Aug 4;S1542-3565(22)00733-9.doi: 10.1016/j.cgh.2022.07.033. Online ahead of print.
Phuc Le 1, Julia Yang Payne 2, Lu Zhang 3, Abhishek Deshpande 4, Michael B Rothberg 4, Naim Alkhouri 5, William Herman 6, Adrian V Hernandez 7, Mary Schleicher 8, Wen Ye 9, Srinivasan Dasarathy 10
|
|
|
141. | Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD |
|
Semin Liver Dis. 2022 Aug;42(3):233-249. doi: 10.1055/s-0042-1755316.Epub 2022 Aug 24.
Raquel Carvalho-Gontijo # 1 2, Cuijuan Han # 1 2, Lei Zhang 1 2, Vivian Zhang 1 2, Mojgan Hosseini 3, Kristin Mekeel 2, Bernd Schnabl 1, Rohit Loomba 1, Michael Karin 4, David A Brenner 1, Tatiana Kisseleva 2
|
|
|
142. | Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis |
|
Clin Gastroenterol Hepatol. 2022 Sep;20(9):2050-2058.e12.doi: 10.1016/j.cgh.2021.07.020. Epub 2021 Jul 15.
Zobair M Younossi 1, Maria Stepanova 2, Fatema Nader 2, Rohit Loomba 3, Quentin M Anstee 4, Vlad Ratziu 5, Stephen Harrison 6, Arun J Sanyal 7, Jörn M Schattenberg 8, A Sidney Barritt 9, Mazen Noureddin 10, Martin Bonacci 11, Gail Cawkwell 11, Bruce Wong 11, Mary Rinella 12, RandomizEd Global Phase 3 Study to Evaluate the Impact on NASH with FibRosis of Obeticholic Acid TreatmEnt (REGENERATE) Study Investigators
|
|
|
143. | Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial |
|
J Hepatol. 2022 Sep;77(3):607-618.doi: 10.1016/j.jhep.2022.04.003.Epub 2022 Apr 16.
Naim Alkhouri 1, Robert Herring 2, Heidi Kabler 3, Zeid Kayali 4, Tarek Hassanein 5, Anita Kohli 6, Ryan S Huss 7, Yanni Zhu 7, Andrew N Billin 7, Lars Holm Damgaard 8, Kristine Buchholtz 8, Mette Skalshøi Kjær 8, Clare Balendran 8, Robert P Myers 7, Rohit Loomba 9, Mazen Noureddin 10
|
|
|
|
|
|
|
|
|
147. | Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis |
|
Clin Gastroenterol Hepatol. 2022 Jul;20(7):1561-1569.e4. doi: 10.1016/j.cgh.2021.06.012.Epub 2021 Jun 10.
Haley Schoenberger 1, Nicolas Chong 1, David T Fetzer 2, Nicole E Rich 1, Takeshi Yokoo 2, Gaurav Khatri 2, Jocelyn Olivares 3, Neehar D Parikh 4, Adam C Yopp 5, Jorge A Marrero 3, Amit G Singal 6
|
|
|
148. | Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients |
|
J Lipid Res. 2022 Jul 11;63(9):100250. doi: 10.1016/j.jlr.2022.100250. Online ahead of print.
Eric J Lawitz 1, Kelvin W Li 2, Edna Nyangau 2, Tyler John Field 2, Jen-Chieh Chuang 3, Andrew Billin 3, Lulu Wang 3, Ya Wang 3, Ryan S Huss 3, Chuhan Chung 3, G Mani Subramanian 3, Robert P Myers 3, Marc K Hellerstein 4
|
|
|
|
|
|
|
|
|
|
|
153. | NASH Presence is Associated with a Lower Weight Loss One and 2 Years After Bariatric Surgery in Women with Severe Obesity |
|
Obes Surg. 2022 Jul 6. doi: 10.1007/s11695-022-06175-w. Online ahead of print.
Fàtima Sabench # 1 2, Laia Bertran # 2, Margarita Vives 1, Marta París 1, Carmen Aguilar 2, Salomé Martínez 2, Jessica Binetti 2 3, Monica Real 3, Alja Alibalic 3, Cristóbal Richart 2, Daniel Del Castillo 1 2, Teresa Auguet 4 5
|
|
|
|
|
|
|
156. | Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD |
|
Radiology. 2022 Jul;304(1):75-82. doi: 10.1148/radiol.211131. Epub 2022 Mar 29.
Jinho Jung 1, Aiguo Han 1, Egbert Madamba 1, Ricki Bettencourt 1, Rohan R Loomba 1, Andrew S Boehringer 1, Michael P Andre 1, John W Erdman Jr 1, William D O'Brien Jr 1, Kathryn J Fowler 1, Claude B Sirlin 1, Rohit Loomba 1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
167. | Living in the non-alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives |
|
Aliment Pharmacol Ther. 2022 Aug;56(4):570-579. doi: 10.1111/apt.17121.Epub 2022 Jul 6.
Cheng Han Ng 1, Wen Hui Lim 1, Yip Han Chin 1, Jie Ning Yong 1, Rebecca Wenling Zeng 1, Kai En Chan 1, Darren Jun Hao Tan 1, Clarissa Elysia Fu 1, Ansel Shao Pin Tang 1, Lay Hoon Goh 2, Kamala Devi 3, Nicholas W S Chew 1 4, Lung-Yi Loey Mak 5, Nobuharu Tamaki 6 7, Daniel Q Huang 1 8 9, Mazen Noureddin 10, Mohammad Shadab Siddiqui 11, Rohit Loomba 6, Arun J Sanyal 11, Mark Muthiah 1 8 9
|
|
|
|
|
|
|
170. | Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study |
|
Nat Med. 2022 Jul;28(7):1432-1438. doi: 10.1038/s41591-022-01861-9.Epub 2022 Jun 20
Stephen A Harrison 1, Federico Perez Manghi 2, William B Smith 3, Diana Alpenidze 4, Diego Aizenberg 5, Naomi Klarenbeek 6, Chi-Yi Chen 7, Eli Zuckerman 8, Eric Ravussin 9, Phunchai Charatcharoenwitthaya 10, Pin-Nan Cheng 11, Helena Katchman 12, Samuel Klein 13, Ziv Ben-Ari 14, Anisha E Mendonza 15, Yiming Zhang 16, Miljen Martic 17, Shenglin Ma 15, Sheena Kao 18, Sandra Tanner 17, Alok Pachori 15, Michael K Badman 15, YanLing He 15, Chinweike Ukomadu 15, Eric Sicard 19
|
|
|
|
|
|
|
173. | Important Food Sources of Fructose-Containing Sugars and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Controlled Trials |
|
Nutrients. 2022 Jul 12;14(14):2846. doi: 10.3390/nu14142846.
Danielle Lee 1 2, Laura Chiavaroli 1 2, Sabrina Ayoub-Charette 1 2, Tauseef A Khan 1 2, Andreea Zurbau 1 2 3, Fei Au-Yeung 1 2 3, Annette Cheung 1 2, Qi Liu 1 2, Xinye Qi 1 2, Amna Ahmed 1 2, Vivian L Choo 1 2 4, Sonia Blanco Mejia 1 2, Vasanti S Malik 1 5, Ahmed El-Sohemy 1, Russell J de Souza 1 2 6 7, Thomas M S Wolever 1 3 8, Lawrence A Leiter 1 2 8 9 10, Cyril W C Kendall 1 2 11, David J A Jenkins 1 2 8 9 10, John L Sievenpiper 1 2 8 9 10
|
|
|
174. | The Association of Metabolic-Associated Fatty Liver Disease with Clinical Outcomes of COVID-19: A Systematic Review and Meta-Analysis |
|
Kans J Med. 2022 Jul 21;15:241-246. doi: 10.17161/kjm.vol15.16522. eCollection 2022.
Umar Hayat 1, Muhammad Zubair Ashfaq 2, Luke Johnson 1, Ryan Ford 1, Chelsea Wuthnow 1, Kevin Kadado 1, Katia El Jurdi 1, Hayrettin Okut 3, William Ransom Kilgore 1 4, Maha Assi 1 5, Ali A Siddiqui 6
|
|
|
175. | Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals |
|
Endocr Pract. 2022 Jul;28(7):667-672. doi: 10.1016/j.eprac.2022.03.016.Epub 2022 Mar 29.
Jingxuan Quek 1, Cheng Han Ng 2, Ansel Shao Pin Tang 1, Nicholas Chew 3, Mark Chan 3, Chin Meng Khoo 4, Chen Poh Wei 1, Yip Han Chin 1, Phoebe Tay 1, Grace Lim 5, Darren Jun Hao Tan 1, Wen Hui Lim 1, Kai En Chan 1, Margaret Teng 6, Eunice Tan 7, Nobuharu Tamaki 8, Daniel Q Huang 7, Mohammad Shadab Siddiqui 9, Dan Yock Young 6, Mazen Noureddin 10, Mark D Muthiah 11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
183. | American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD) |
|
Endocr Pract. 2022 May;28(5):528-562. doi: 10.1016/j.eprac.2022.03.010.
Kenneth Cusi 1, Scott Isaacs 2, Diana Barb 3, Rita Basu 4, Sonia Caprio 5, W Timothy Garvey 6, Sangeeta Kashyap 7, Jeffrey I Mechanick 8, Marialena Mouzaki 9, Karl Nadolsky 10, Mary E Rinella 11, Miriam B Vos 12, Zobair Younossi 13
|
|
|
|
|
|
|
|
|
|
|
|
|
189. | Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniques |
|
Obes Rev. 2022 Jun 12. doi: 10.1111/obr.13481. Online ahead of print.
Willy Theel 1 2, Bianca M Boxma-de Klerk 3, Femme Dirksmeier-Harinck 4, Elisabeth F C van Rossum 2 5, Danny A Kanhai 6, Jan Apers 7, Bas M van Dalen 8, Robert J de Knegt 9, Anthony G Holleboom 10, Maarten E Tushuizen 11, Diederick E Grobbee 12 13, Janneke Wiebolt 1 2, Manuel Castro Cabezas 1 5 13
|
|
|
190. | The Role of Macronutrients in the Pathogenesis, Prevention and Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Paediatric Population-A Review |
|
Life (Basel). 2022 Jun 5;12(6):839. doi: 10.3390/life12060839.
Thomas Pixner 1 2, Nathalie Stummer 2 3, Anna Maria Schneider 2 3, Andreas Lukas 1 2, Karin Gramlinger 1, Valérie Julian 4, David Thivel 5, Katharina Mörwald 2 3, Katharina Maruszczak 2 3, Harald Mangge 6, Julian Gomahr 2 3, Daniel Weghuber 2 3, Dieter Furthner 1 2
|
|
|
|
|
|
|
193. | Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease |
|
Cureus. 2022 May 30;14(5):e25495. doi: 10.7759/cureus.25495.eCollection 2022 May.
Gashaw Hassen 1 2 3 4, Abhishek Singh 5, Gizeshwork Belete 6, Nidhi Jain 7 8 9, Ivonne De la Hoz 10, Genesis P Camacho-Leon 11 12, Nitsuh K Dargie 13, Keila G Carrera 14, Tadesse Alemu 15, Sharan Jhaveri 16, Nebiyou Solomon 15
|
|
|
|
|
|
|
|
|
|
|
|
|
199. | Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants |
|
Gastroenterology. 2022 Jul 1;S0016-5085(22)00735-1. doi: 10.1053/j.gastro.2022.06.073.Online ahead of print.
Veeral Ajmera 1, Beom Kyung Kim 2, Kun Yang 3, Abdul M Majzoub 4, Tarek Nayfeh 5, Nobuharu Tamaki 6, Namiki Izumi 7, Atsushi Nakajima 8, Ramazan Idilman 9, Mesut Gumussoy 9, Digdem Kuru Oz 10, Ayse Erden 10, Natalie E Quach 3, Xin Tu 3, Xinlian Zhang 3, Mazen Noureddin 11, Alina M Allen 12, Rohit Loomba 13
|
|
|
|
|
|
|
|
|
|
|
204. | Reduction of De Novo Lipogenesis Mediates Beneficial Effects of Isoenergetic Diets on Fatty Liver: Mechanistic Insights from the MEDEA Randomized Clinical Trial |
|
Nutrients. 2022 May 23;14(10):2178. doi: 10.3390/nu14102178.
Giuseppina Costabile 1 2, Giuseppe Della Pepa 1, Dominic Salamone 1, Delia Luongo 3, Daniele Naviglio 4, Valentina Brancato 5, Carlo Cavaliere 5, Marco Salvatore 5, Paola Cipriano 1, Marilena Vitale 1, Alessandra Corrado 1, Angela Albarosa Rivellese 1 2, Giovanni Annuzzi 1 2, Lutgarda Bozzetto 1 2
|
|
|
|
|
|
|
|
|
208. | Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease |
|
JHEP Rep. 2022 Mar 26;4(5):100477. doi: 10.1016/j.jhepr.2022.100477. eCollection 2022 May.
Aidan J McGlinchey 1, Olivier Govaere 2, Dawei Geng 3, Vlad Ratziu 4, Michael Allison 5, Jerome Bousier 6, Salvatore Petta 7, Claudia de Oliviera 8, Elisabetta Bugianesi 9, Jörn M Schattenberg 10, Ann K Daly 2, Tuulia Hyötyläinen 3, Quentin M Anstee 2 11, Matej Orešic 1 12
|
|
|
|
|
210. | Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association |
|
Arterioscler Thromb Vasc Biol. 2022 Jun;42(6):e168-e185.doi: 10.1161/ATV.0000000000000153. Epub 2022 Apr 14.
P Barton Duell, Francine K Welty, Michael Miller, Alan Chait, Gmerice Hammond, Zahid Ahmad, David E Cohen, Jay D Horton, Gregg S Pressman, Peter P Toth, American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Hypertension; Council on the Kidney in Cardiovascular Disease; Council on Lifestyle and Cardiometabolic Health; and Council on Peripheral Vascular Disease
|
|
|
| | | | | |